Insulin vs. pills: which is safer for gestational diabetes?

NCT ID NCT07582471

Completed Disease control Sponsor: Dr Mudassar Saeed Pansota Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared insulin injections and metformin pills in 60 pregnant women with gestational diabetes to see which is safer and more effective. Participants were randomly assigned to receive either insulin or metformin, and researchers monitored blood sugar levels and newborn health. The goal is to find the best treatment to prevent complications for both mother and baby.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Insulin (Humulin R) and metformin
What this could lead to: If successful, this could help doctors choose the safer and more effective medication for managing gestational diabetes, reducing risks for both mother and baby.
What could go wrong: This is a small, completed study with only 60 participants, so results may not apply to all pregnant women. Both treatments have known risks, and the study does not guarantee long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES MELLITUS (GDM)

Contacts and locations

Locations

Shahida Islam Teaching Hospital

Lodhran, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.